Processing of Routine Clinical Data Using Large Language Models Such As GPT-4 — IMPL-AI-MENT  

COPD Clinical Trial

Official title: Processing of Routine Clinical Data Using Large Language Models Such As GPT-4

Status Not yet recruiting

Clinical Trial Summary

According to studies in the US and the Netherlands, 33-40% of patients with chronic conditions receive care that does not follow guideline recommendations. These findings have also been demonstrated in the management of COPD. This leads to under- or over-treatment of patients and, in the case of COPD, to exacerbations and hospitalisations. These exacerbations are a significant clinical problem, affecting patient's lung function, quality of life and mortality. They are also a burden on the healthcare system. Technological advances in artificial intelligence offer the opportunity to address these issues in COPD management. In the past year, there have been remarkable innovations in the field of natural language processing, especially through large language models such as GPT-4 from OpenAI and Bard or Gemini from Google. These models offer an opportunity to improve the implementation of evidence-based care in clinical practice. This study is a prospective, randomised trial that will compare therapy on discharge for patients with COPD. One arm will receive no intervention, while the other arm will receive a treatment recommendation from an LLM. The study will compare the percentage of patients treated according to the guideline.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• COPD

• NCT number: NCT06410547
• Study type: Interventional
• Source: Charite University, Berlin, Germany
• Contact: Matthias Gröschel, MD PhD
• Phone: +4915906714937
• Email: matthias.groeschel@charite.de
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 15, 2024
• Completion date: September 30, 2024